Header Logo

Connection

David Bennett to Neurofibrillary Tangles

Back to Details
This is a "connection" page, showing publications David Bennett has written about Neurofibrillary Tangles.
David Bennett
Connection Strength
6.052
Neurofibrillary Tangles
  1. Association of Cortical ?-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. JAMA Neurol. 2019 07 01; 76(7):818-826.
    View in: PubMed
    Score: 0.613
  2. Modification of the relationship of the apolipoprotein E e4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013 Dec; 70(12):1544-51.
    View in: PubMed
    Score: 0.416
  3. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology. 2008 Jun 03; 70(23):2219-25.
    View in: PubMed
    Score: 0.285
  4. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry. 2007 Jan; 78(1):30-5.
    View in: PubMed
    Score: 0.253
  5. Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol. 2006 Jan; 59(1):166-73.
    View in: PubMed
    Score: 0.241
  6. Education modifies the association of amyloid but not tangles with cognitive function. Neurology. 2005 Sep 27; 65(6):953-5.
    View in: PubMed
    Score: 0.236
  7. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol. 2004 Mar; 61(3):378-84.
    View in: PubMed
    Score: 0.212
  8. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology. 2003 Oct 28; 61(8):1102-7.
    View in: PubMed
    Score: 0.207
  9. Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology. 2023 04 04; 100(14):e1474-e1487.
    View in: PubMed
    Score: 0.196
  10. Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia. J Alzheimers Dis. 2023; 96(2):563-578.
    View in: PubMed
    Score: 0.195
  11. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease. Mol Neurodegener. 2017 07 01; 12(1):51.
    View in: PubMed
    Score: 0.133
  12. Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies. Mol Psychiatry. 2018 06; 23(6):1521-1529.
    View in: PubMed
    Score: 0.131
  13. Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology. AJNR Am J Neuroradiol. 2017 May; 38(5):961-965.
    View in: PubMed
    Score: 0.131
  14. A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease. Alzheimers Dement. 2017 Jun; 13(6):674-688.
    View in: PubMed
    Score: 0.129
  15. Temporal course of neurodegenerative effects on cognition in old age. Neuropsychology. 2016 07; 30(5):591-9.
    View in: PubMed
    Score: 0.123
  16. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 08; 12(8):882-9.
    View in: PubMed
    Score: 0.121
  17. Association of DNA methylation in the brain with age in older persons is confounded by common neuropathologies. Int J Biochem Cell Biol. 2015 Oct; 67:58-64.
    View in: PubMed
    Score: 0.115
  18. Associations of cerebrovascular and Alzheimer's disease pathology with brain atrophy. Curr Alzheimer Res. 2014 May; 11(4):309-16.
    View in: PubMed
    Score: 0.107
  19. Brain tocopherols related to Alzheimer's disease neuropathology in humans. Alzheimers Dement. 2015 Jan; 11(1):32-9.
    View in: PubMed
    Score: 0.106
  20. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014 Apr; 35(4):819-26.
    View in: PubMed
    Score: 0.103
  21. A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging. 2014 Feb; 35(2):301-8.
    View in: PubMed
    Score: 0.103
  22. Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology. 2013 Mar 26; 80(13):1202-8.
    View in: PubMed
    Score: 0.099
  23. Terminal dedifferentiation of cognitive abilities. Neurology. 2012 Apr 10; 78(15):1116-22.
    View in: PubMed
    Score: 0.093
  24. Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry. 2011 Apr; 19(4):327-34.
    View in: PubMed
    Score: 0.087
  25. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. Am J Hum Genet. 2011 Feb 11; 88(2):232-8.
    View in: PubMed
    Score: 0.086
  26. Neurodegenerative basis of age-related cognitive decline. Neurology. 2010 Sep 21; 75(12):1070-8.
    View in: PubMed
    Score: 0.083
  27. Loss of basic lexical knowledge in old age. J Neurol Neurosurg Psychiatry. 2011 Apr; 82(4):369-72.
    View in: PubMed
    Score: 0.083
  28. Plaque complement activation and cognitive loss in Alzheimer's disease. J Neuroinflammation. 2008 Mar 11; 5:9.
    View in: PubMed
    Score: 0.070
  29. Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch Gen Psychiatry. 2007 Oct; 64(10):1204-12.
    View in: PubMed
    Score: 0.068
  30. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology. 2006 Dec 12; 67(11):1960-5.
    View in: PubMed
    Score: 0.064
  31. Memory complaints are related to Alzheimer disease pathology in older persons. Neurology. 2006 Nov 14; 67(9):1581-5.
    View in: PubMed
    Score: 0.064
  32. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005 Jun; 62(6):685-91.
    View in: PubMed
    Score: 0.058
  33. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005 Mar 08; 64(5):834-41.
    View in: PubMed
    Score: 0.057
  34. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J Neurosci. 2004 Sep 08; 24(36):7895-902.
    View in: PubMed
    Score: 0.055
  35. Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. Nat Commun. 2023 Nov 30; 14(1):7659.
    View in: PubMed
    Score: 0.052
  36. Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density. Am J Pathol. 2003 Oct; 163(4):1615-21.
    View in: PubMed
    Score: 0.051
  37. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology. 2003 Jun 24; 60(12):1909-15.
    View in: PubMed
    Score: 0.050
  38. Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities. Neurobiol Dis. 2022 Nov; 174:105880.
    View in: PubMed
    Score: 0.048
  39. Improved detection of substantia nigra pathology in Alzheimer's disease. J Histochem Cytochem. 2002 Jan; 50(1):99-106.
    View in: PubMed
    Score: 0.046
  40. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
    View in: PubMed
    Score: 0.046
  41. Sex-Specific Association of the X Chromosome With Cognitive Change and Tau Pathology in Aging and Alzheimer Disease. JAMA Neurol. 2021 10 01; 78(10):1249-1254.
    View in: PubMed
    Score: 0.045
  42. Epigenomic features related to microglia are associated with attenuated effect of APOE e4 on Alzheimer's disease risk in humans. Alzheimers Dement. 2022 04; 18(4):688-699.
    View in: PubMed
    Score: 0.045
  43. Bayesian Genome-wide TWAS Method to Leverage both cis- and trans-eQTL Information through Summary Statistics. Am J Hum Genet. 2020 10 01; 107(4):714-726.
    View in: PubMed
    Score: 0.042
  44. Quantitative Assessment of Pathological Tau Burden in Essential Tremor: A Postmortem Study. J Neuropathol Exp Neurol. 2019 01 01; 78(1):31-37.
    View in: PubMed
    Score: 0.037
  45. DNA methylation variability in Alzheimer's disease. Neurobiol Aging. 2019 04; 76:35-44.
    View in: PubMed
    Score: 0.037
  46. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018 08 01; 75(8):989-998.
    View in: PubMed
    Score: 0.036
  47. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol. 2018 01; 135(1):85-93.
    View in: PubMed
    Score: 0.034
  48. Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging. 2018 01; 61:138-145.
    View in: PubMed
    Score: 0.034
  49. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease. J Neuropathol Exp Neurol. 2017 Feb 01; 76(2):70-88.
    View in: PubMed
    Score: 0.032
  50. Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology. J Alzheimers Dis. 2017; 56(2):699-706.
    View in: PubMed
    Score: 0.032
  51. Soluble Conformers of A? and Tau Alter Selective Proteins Governing Axonal Transport. J Neurosci. 2016 09 14; 36(37):9647-58.
    View in: PubMed
    Score: 0.032
  52. A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol. 2015 Mar; 77(3):469-77.
    View in: PubMed
    Score: 0.028
  53. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease. Neurobiol Aging. 1993 Nov-Dec; 14(6):589-96.
    View in: PubMed
    Score: 0.026
  54. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis. 2013 Aug 15; 208(4):564-72.
    View in: PubMed
    Score: 0.025
  55. The complex PrP(c)-Fyn couples human oligomeric A? with pathological tau changes in Alzheimer's disease. J Neurosci. 2012 Nov 21; 32(47):16857-71a.
    View in: PubMed
    Score: 0.024
  56. Correlation of amyloid PET ligand florbetapir F 18 binding with A? aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord. 2012 Jan-Mar; 26(1):8-16.
    View in: PubMed
    Score: 0.023
  57. Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol Aging. 2011 Dec; 32(12):2113-22.
    View in: PubMed
    Score: 0.020
  58. Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol. 2007 Apr; 170(4):1200-9.
    View in: PubMed
    Score: 0.016
  59. The significance of Pin1 in the development of Alzheimer's disease. J Alzheimers Dis. 2007 Mar; 11(1):13-23.
    View in: PubMed
    Score: 0.016
  60. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology. Acta Neuropathol. 2005 Aug; 110(2):135-44.
    View in: PubMed
    Score: 0.015
  61. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 2006 Feb; 27(2):252-61.
    View in: PubMed
    Score: 0.014
  62. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol. 2002 Oct; 177(2):475-93.
    View in: PubMed
    Score: 0.012
  63. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol. 2002 Feb; 51(2):182-9.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.